Parkinson's disease: prospects for improved drug therapy

This publication has 44 references indexed in Scilit:

• Does levodopa therapy delay death in Parkinson's disease? A review of the evidence
  Movement Disorders, 1995
• Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia
  Biological Psychiatry, 1993
• Is levodopa harmful?
  The Lancet, 1991
• “Early” initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease
  Neurology, 1991
• Nigrostriatal Damage is Required for Induction of Dyskinesias by l-DOPA in Squirrel Monkeys
  Clinical Neuropharmacology, 1990
• Young onset Parkinson's disease
  Movement Disorders, 1987
• Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapy
  Neurology, 1979
• SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE
  The Lancet, 1977
• Parkinsonism
  Neurology, 1967
• Aromatic Amino Acids and Modification of Parkinsonism
  New England Journal of Medicine, 1967